Clinical Quiz: HCV DAA Treatment After Solid Organ Transplantation

Quiz
Article

This clinical quiz will test your knowledge of the 2023 American Association for the Study of Liver Diseases/Infectious Diseases Society of America Hepatitis C guideline.

Clinician and liver | Credit: Pixabay

Credit: Pixabay

Since 2013, the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases have worked together to develop evidence-based guidance for the diagnosis, management, and treatment of hepatitis C virus (HCV) infection.

This update to the previous 2020 guidelines was released in 2023 and reflects our current understanding of the infection with timely, evidence-based guidance spotlighting major changes related to screening, organ transplantation, and expanded treatment options for children and adolescents.

Test your knowledge of the 2023 HCV guidance update below:

When should treatment be initiated for HCV-uninfected recipients of liver grafts from HCV-viremic donors using glecaprevir/pibrentasvir?


Reference:

  1. Bhattacharya D, Aronsohn A, Price J, Lo Re V; AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. Published online May 25, 2023. doi:10.1093/cid/ciad319

Editors' note: Artificial intelligence aided in the creation of this content.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
1 KOL is featured in this Insights series.
© 2024 MJH Life Sciences

All rights reserved.